RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Akebia Therapeutics Stock

Akebia Therapeutics Net Income 2024

Akebia Therapeutics Net Income

-52.19 M USD

Ticker

AKBA

ISIN

US00972D1054

WKN

A1XF0S

In 2024, Akebia Therapeutics's profit amounted to -52.19 M USD, a 0.52% increase from the -51.93 M USD profit recorded in the previous year.

The Akebia Therapeutics Net Income history

YEARNET INCOME (undefined USD)
2029e514.79
2028e233.8
2027e110.47
2026e31.1
2025e-55.05
2024e-52.19
2023-51.93
2022-94.2
2021-282
2020-384.8
2019-279.7
2018-143.6
2017-73.7
2016-135.7
2015-60.7
2014-123.9
2013-69.1
2012-11.5
2011-18.3

Akebia Therapeutics Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Akebia Therapeutics, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Akebia Therapeutics from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Akebia Therapeutics’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Akebia Therapeutics. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Akebia Therapeutics’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Akebia Therapeutics’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Akebia Therapeutics’s growth potential.

Akebia Therapeutics Revenue, EBIT and net profit per share

DateAkebia Therapeutics RevenueAkebia Therapeutics EBITAkebia Therapeutics Net Income
2029e830.17 M undefined0 undefined514.79 M undefined
2028e452.89 M undefined248.47 M undefined233.8 M undefined
2027e334 M undefined119.2 M undefined110.47 M undefined
2026e251.37 M undefined37.69 M undefined31.1 M undefined
2025e181.1 M undefined-63.09 M undefined-55.05 M undefined
2024e175.44 M undefined-48.17 M undefined-52.19 M undefined
2023194.62 M undefined-44.48 M undefined-51.93 M undefined
2022292.5 M undefined-34.7 M undefined-94.2 M undefined
2021211.7 M undefined-249.5 M undefined-282 M undefined
2020294.6 M undefined-242.8 M undefined-384.8 M undefined
2019335 M undefined-286.3 M undefined-279.7 M undefined
2018207.7 M undefined-178.2 M undefined-143.6 M undefined
2017181.2 M undefined-76.7 M undefined-73.7 M undefined
20161.5 M undefined-136.5 M undefined-135.7 M undefined
20150 undefined-61.5 M undefined-60.7 M undefined
20140 undefined-37.9 M undefined-123.9 M undefined
20130 undefined-15.9 M undefined-69.1 M undefined
20120 undefined-8.5 M undefined-11.5 M undefined
20110 undefined-15.5 M undefined-18.3 M undefined

Akebia Therapeutics stock margins

The Akebia Therapeutics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Akebia Therapeutics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Akebia Therapeutics.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Akebia Therapeutics's sales revenue. A higher gross margin percentage indicates that the Akebia Therapeutics retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Akebia Therapeutics's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Akebia Therapeutics's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Akebia Therapeutics's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Akebia Therapeutics. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Akebia Therapeutics's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Akebia Therapeutics Margin History

Akebia Therapeutics Gross marginAkebia Therapeutics Profit marginAkebia Therapeutics EBIT marginAkebia Therapeutics Profit margin
2029e79.58 %0 %62.01 %
2028e79.58 %54.86 %51.62 %
2027e79.58 %35.69 %33.07 %
2026e79.58 %14.99 %12.37 %
2025e79.58 %-34.84 %-30.4 %
2024e79.58 %-27.46 %-29.75 %
202379.58 %-22.85 %-26.68 %
202292.31 %-11.86 %-32.21 %
202151.25 %-117.86 %-133.21 %
202055.13 %-82.42 %-130.62 %
201966.42 %-85.46 %-83.49 %
201896.97 %-85.8 %-69.14 %
2017100 %-42.33 %-40.67 %
201679.58 %-9,100 %-9,046.67 %
201579.58 %0 %0 %
201479.58 %0 %0 %
201379.58 %0 %0 %
201279.58 %0 %0 %
201179.58 %0 %0 %

Akebia Therapeutics Aktienanalyse

What does Akebia Therapeutics do?

Akebia Therapeutics Inc. is a biopharmaceutical company based in Cambridge, Massachusetts, USA. The company was founded in 2007 and focuses on the development and marketing of medications for the treatment of kidney diseases and other diseases. Akebia Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Akebia Therapeutics's Profit Margins

The profit margins of Akebia Therapeutics represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Akebia Therapeutics's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Akebia Therapeutics's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Akebia Therapeutics's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Akebia Therapeutics’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Akebia Therapeutics stock

How much profit has Akebia Therapeutics made this year?

Akebia Therapeutics has made -52.19 M USD this year.

How has the profit developed compared to last year?

The profit has increased by 0.52% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Akebia Therapeutics publish its earnings?

Akebia Therapeutics publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Akebia Therapeutics?

The profits of Akebia Therapeutics are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Akebia Therapeutics?

You can learn more about the earnings of Akebia Therapeutics by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Akebia Therapeutics pay?

Over the past 12 months, Akebia Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Akebia Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Akebia Therapeutics?

The current dividend yield of Akebia Therapeutics is .

When does Akebia Therapeutics pay dividends?

Akebia Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Akebia Therapeutics?

Akebia Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Akebia Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Akebia Therapeutics located?

Akebia Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Akebia Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Akebia Therapeutics from 10/30/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/30/2024.

When did Akebia Therapeutics pay the last dividend?

The last dividend was paid out on 10/30/2024.

What was the dividend of Akebia Therapeutics in the year 2023?

In the year 2023, Akebia Therapeutics distributed 0 USD as dividends.

In which currency does Akebia Therapeutics pay out the dividend?

The dividends of Akebia Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Akebia Therapeutics stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Akebia Therapeutics

Our stock analysis for Akebia Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Akebia Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.